Link between schizophrenia and sleep apnoea

August 24, 2016, University of Adelaide
Functional magnetic resonance imaging (fMRI) and other brain imaging technologies allow for the study of differences in brain activity in people diagnosed with schizophrenia. The image shows two levels of the brain, with areas that were more active in healthy controls than in schizophrenia patients shown in orange, during an fMRI study of working memory. Credit: Kim J, Matthews NL, Park S./PLoS One.

New University of Adelaide research at the Lyell McEwin Hospital has shown that people with schizophrenia are 3.4 times more likely to have severe obstructive sleep apnoea than people without.

The study, which incorporated home sleep studies on 32 patients with , is the first of its kind worldwide to confirm a link between schizophrenia and obstructive sleep apnoea.

Northern Adelaide Local Health Network Senior Consultant Psychiatrist and University of Adelaide Professor Cherrie Galletly said most patients with schizophrenia report difficulties with their sleep.

"People with schizophrenia have much higher rates of physical illness like diabetes, obesity and , and this causes a 17-20 year reduction in their life expectancy," Professor Galletly said.

"Despite these illnesses being closely linked with obstructive sleep apnoea, the rates of this disorder and the benefits of treating it in this population are unknown.

"People with obstructive sleep apnoea also have high rates of heart disease, depression and poor memory, so obstructive sleep apnoea may be causing these problems in many people with schizophrenia, but no one is aware of this."

The study is examining the acceptability and effectiveness of continuous positive to treat people with schizophrenia and severe sleep apnoea.

University of Adelaide PhD student Dr Hannah Myles said the treatment uses mild air pressure to keep the airways open.

"Obstructive sleep apnoea is often treated with continuous positive airway pressure but there are no studies that have investigated whether people with schizophrenia would be able to use this treatment, or if it would work to improve their obstructive sleep apnoea, memory, depressed moods, and problems," Dr Myles said.

"Our study is the first in the world to demonstrate that people with schizophrenia will accept the diagnostic methods used to identify obstructive sleep apnoea, and will tolerate the continuous positive airway pressure therapy.

"So far six participants have received this treatment, all with positive results."

The study found continuous positive airway pressure improved the severity of , memory and the physical health of participants; it has also helped to restore normal brain activity during sleep.

"The most exciting and unexpected result was that after six months of treatment, participants lost on average 13.6 kilograms," Dr Myles said.

"This provides hope that continuous positive airway pressure may be a new way to help treat the physical health of people with schizophrenia."

The study gives evidence that patients with schizophrenia are able to tolerate the test and this kind of therapy.

Explore further: CPAP improves work productivity for sleep apnea patients

More information: H. Myles et al. How long will we sleep on obstructive sleep apnoea in schizophrenia?, Australian & New Zealand Journal of Psychiatry (2016). DOI: 10.1177/0004867416662919

Related Stories

CPAP improves work productivity for sleep apnea patients

April 10, 2013
Continuous positive airway pressure is effective at increasing work productivity, according to a new study.

Study finds high rates of sleep apnea in women

August 15, 2012
New research has found high rates of sleep apnoea in women, despite the condition usually being regarded as a disorder predominantly of males.

Sleep apnea treatment may reverse unhealthy brain changes

September 15, 2015
(HealthDay)—Sleep apnea treatment may reverse changes in brain stem activity associated with increased risk of heart disease, a new study suggests.

Low-energy diet can improve sleep disorder

June 2, 2011
Sufferers of the sleep disorder obstructive sleep apnoea could benefit from following a low energy diet to lose weight, finds research published in the British Medical Journal today.

Severity of sleep apnoea predicts aggressiveness of melanoma

September 9, 2013
The severity of sleep apnoea can independently predict the aggressiveness of malignant skin melanoma, according to a new study.

Playing a wind instrument could help lower the risk of sleep apnea

April 16, 2015
A new study has found that wind instrument players have a reduced risk of developing obstructive sleep apnoea.

Recommended for you

Sleep apnea, congenital heart disease may be deadly mix for hospitalized infants

September 17, 2018
Infants often aren't screened for sleep apnea, but a new study suggests the disorder may be tied to an increased risk of death in infants with congenital heart disease.

Sleep deficiency increases risk of a motor vehicle crash

April 4, 2018
Excessive sleepiness can cause cognitive impairments and put individuals at a higher risk of motor vehicle crash. However, the perception of impairment from excessive sleepiness quickly plateaus in individuals who are chronically ...

Sleep apnea study finds male-female differences in cerebral cortex thickness, symptoms

March 13, 2018
Researchers from the UCLA School of Nursing examined clinical records and magnetic resonance imaging brain scans of patients who were recently diagnosed with sleep apnea, and discovered several apparent connections between ...

Synthetic cannabinoid reduces sleep apnea

November 29, 2017
A synthetic version of a molecule found in the cannabis plant was safe and effective in treating obstructive sleep apnea in the first large, multi-site study of a drug for the sleep disorder funded by the National Institutes ...

Sleeping through the snoring: Researchers identify neurons that rouse the brain to breathe

November 2, 2017
A common and potentially serious sleep disorder, obstructive sleep apnea affects at least one quarter of U.S. adults and is linked to increased risk of diabetes, obesity and cardiovascular disease. In a paper published today ...

Remede system approved for sleep apnea

October 9, 2017
(HealthDay)—The Remede sleep system, an implanted device that treats central sleep apnea by activating a nerve that sends signals to the diaphragm to stimulate breathing, has been approved by the U.S. Food and Drug Administration.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.